Fluticasone Export Market Intelligence: India's 239 Suppliers Shipping to 123 Countries — TransData Nexus 2026

Q: Who are the top fluticasone exporters from India?

The top fluticasone exporters from India are: 1. CIPLA LIMITED — $184.7M (91.0% market share); 2. HETERO LABS LIMITED — $4.5M (2.2% market share); 3. MEDISPRAY LABORATORIES PRIVATE LIMITED — $2.6M (1.3% market share); 4. ZYDUS LIFESCIENCES LIMITED — $1.7M (0.8% market share); 5. SAVA HEALTHCARE LIMITED — $1.1M (0.5% market share). Together they account for 95.9% of India's total fluticasone export value.

Q: What is the total export value of fluticasone from India?

The total export value of fluticasone from India is $203.0M USD, recorded across 9,009 shipment transactions from 239 active exporters to 123 destination countries. The average shipment value is $22.5K.

Q: Which countries import fluticasone from India?

India exports fluticasone to 123 countries worldwide. The top importing countries are: NETHERLANDS (34.2% share, $69.4M), AUSTRALIA (10.1% share, $20.4M), CANADA (5.9% share, $11.9M), SOUTH AFRICA (5.4% share, $10.9M), TURKEY (4.2% share, $8.5M). These five markets account for 59.7% of total export value.

Q: What is the HS code for fluticasone exports from India?

The primary HS code for fluticasone exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of fluticasone exports from India?

The average unit price for fluticasone exports from India is $17.14 USD per unit, with prices ranging from $0.01 to $3871.76 depending on formulation, packaging, and order volume. The total market is valued at $203.0M across 9,009 shipments.

Q: Which ports handle fluticasone exports from India?

The primary ports for fluticasone exports from India are SAHAR AIR (22.3% of shipments), DELHI AIR (14.1% of shipments), DELHI AIR CARGO ACC (INDEL4) (13.8% of shipments), SAHAR AIR CARGO ACC (INBOM4) (10.9% of shipments), NHAVA SHEVA SEA (INNSA1) (5.3% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of fluticasone?

India is one of the world's leading exporters of fluticasone due to its large base of 239 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports fluticasone to 123 countries, demonstrating 63% global market coverage.

Q: What certifications do Indian fluticasone exporters need?

Indian fluticasone exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import fluticasone from India?

There are 664 registered buyers importing fluticasone from India, spread across 123 countries. The repeat buyer rate is 62.3%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top fluticasone supplier from India?

CIPLA LIMITED is the leading fluticasone exporter from India with a market share of 91.0% and total export value of $184.7M across 2663 shipments. The top 5 suppliers together control 95.9% of total export value.

Suresh Sormare

Fluticasone

India Pharmaceutical Trade Intelligence

$203.0M239 Suppliers123 CountriesHS 30049099

ExportsIndia → NETHERLANDS34.2%India → AUSTRALIA10.1%

ImportsUNITED KINGDOM → India$2.6B UNITED STATES → India$54.3M

#1 Supplier: CIPLA LIMITED

Fluticasone Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Fluticasone to the World

Between 2022 and 2026, India exported $203.0M worth of fluticasone across 9,009 verified shipments to 123 countries — covering 63% of world markets in the Respiratory segment. The largest destination is NETHERLANDS (34.2%). CIPLA LIMITED leads with a 91.0% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published May 2026·Updated May 2026·HS 30049099

Fluticasone export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Fluticasone export data snapshot — $203.0M · 239 exporters · 123 countriesTransData Nexus · Indian Customs Data

Top Fluticasone Exporters from India

239 active exporters · Ranked by export value

View all 239 →

Top Fluticasone Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	CIPLA LIMITED	$184.7M	2,663	53	91.0%
2	HETERO LABS LIMITED

Top Countries Importing Fluticasone from India

123 destination markets · Ranked by import value

All 123 countries →

Top Countries Importing Fluticasone from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	NETHERLANDS	$69.4M	34.2%
2	AUSTRALIA	$20.4M	10.1%
3	CANADA	$11.9M	5.9%
4	SOUTH AFRICA	$10.9M	5.4%
5	TURKEY	$8.5M	4.2%
6	CHILE	$7.8M	3.8%
7	UNITED ARAB EMIRATES	$6.7M	3.3%
8	UNITED STATES	$6.5M	3.2%
9	BELGIUM	$5.6M	2.8%
10	BRAZIL	$5.3M	2.6%

NETHERLANDS is India's largest fluticasone export destination, absorbing 34.2% of total exports worth $69.4M. The top 5 importing countries — NETHERLANDS, AUSTRALIA, CANADA, SOUTH AFRICA, TURKEY — together account for 59.7% of India's total fluticasone export value. The remaining 118 destination countries collectively receive the other 40.3%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Fluticasone to India?

19 origin countries · Total import value: $2.7B

India imports fluticasone from 19 countries with a combined import value of $2.7B. The largest supplier is UNITED KINGDOM ($2.6B, 33 shipments), followed by UNITED STATES and BRAZIL. All values are from Indian Customs (DGFT) import records.

Countries Supplying Fluticasone to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED KINGDOM	$2.6B	33	97.3%
2	UNITED STATES	$54.3M	243	2.0%
3	BRAZIL	$8.7M	16	0.3%
4	NETHERLANDS	$4.8M	3	0.2%
5	CANADA	$4.0M	25	0.1%
6	CHINA	$107.1K	19	0.0%
7	GERMANY	$95.2K	38	0.0%
8	SPAIN	$94.7K	3	0.0%
9	IRELAND	$72.2K	21	0.0%
10	FRANCE	$51.3K	1	0.0%

Showing top 10 of 19 origin countries

UNITED KINGDOM is the largest supplier of fluticasone to India, accounting for 97.3% of total import value. The top 5 origin countries — UNITED KINGDOM, UNITED STATES, BRAZIL, NETHERLANDS, CANADA — together supply 100.0% of India's fluticasone imports. Click any country to see detailed supplier and buyer data for that import corridor.

Fluticasone — Export Intelligence Video

Visual overview of India's fluticasone import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's fluticasone pharmaceutical import and export market — $203.0M in total trade, 239 verified manufacturers, and 123 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Fluticasone

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, fluticasone products are subject to the Food and Drug Administration's (FDA) rigorous approval processes. The FDA's Orange Book lists numerous approved Abbreviated New Drug Applications (ANDAs) for fluticasone, indicating a competitive generic market. Recent approvals include:

- Fluticasone Propionate Nasal Spray: Approved in March 2025.

- Fluticasone Furoate Inhalation Powder: Approved in June 2025.

These approvals reflect the FDA's ongoing evaluation and authorization of fluticasone formulations. Notably, there are no current import alerts related to fluticasone, suggesting compliance with FDA standards among exporters. Given the presence of 239 active Indian exporters, adherence to the FDA's stringent regulatory requirements is imperative for market access.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), fluticasone-containing products require marketing authorization from the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA), respectively. For instance, the EMA granted marketing authorization for Avamys (fluticasone furoate) on January 11, 2008, for the treatment of allergic rhinitis. Manufacturers must comply with EU Good Manufacturing Practice (GMP) guidelines to ensure product quality and safety.

3WHO Essential Medicines & Global Standards

Fluticasone is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in global health. The drug is also subject to standards set forth in various pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality across different markets.

4India Regulatory Classification

In India, fluticasone is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has set a ceiling price for fluticasone-containing formulations, with the latest revision in September 2025. Exporters are required to obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceutical products, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The primary patents for fluticasone have expired, leading to increased generic competition globally. This has facilitated the entry of multiple manufacturers into the market, contributing to the availability and affordability of fluticasone products.

6Recent Industry Developments

In the past 12 months, several notable developments have occurred:

- April 2025: The EMA withdrew the marketing authorization for Airexar Spiromax (salmeterol/fluticasone propionate) at the request of the marketing authorization holder, Teva B.V., due to commercial reasons. (ema.europa.eu)

- June 2025: The FDA approved a new generic version of fluticasone propionate nasal spray, expanding treatment options for allergic rhinitis.

- September 2025: The NPPA revised the ceiling price for fluticasone-containing formulations, reflecting changes in market dynamics and cost structures.

These developments highlight the dynamic nature of the pharmaceutical industry and the importance of staying abreast of regulatory changes and market trends.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Fluticasone

Retail & reference prices across 9 markets vs. India FOB export price of $17.14/unit

Global Price Benchmark for Fluticasone across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$28.94 per gram	USD	According to the FDA Orange Book, fluticasone inhalers are approved for use in the United States.
United Kingdom	Data not available	GBP	Fluticasone inhalers are listed in the NHS Drug Tariff, indicating their availability and regulated pricing within the National Health Service.
Germany	Data not available	EUR	Fluticasone inhalers are approved by the European Medicines Agency (EMA) for use in Germany.
Australia	Data not available

Supply Chain Risk Assessment — Fluticasone

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Fluticasone, a corticosteroid used in various respiratory treatments, relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) for its production. India, a major exporter of Fluticasone, sources a significant portion of these critical components from China. According to a 2025 report by the U.S. Pharmacopeia, 41% of KSMs used for U.S.-approved APIs are solely sourced from China, highlighting a substantial dependency. This reliance exposes the supply chain to potential disruptions stemming from geopolitical tensions, trade restrictions, or environmental regulations affecting Chinese manufacturing.

The COVID-19 pandemic underscored the vulnerabilities associated with this dependency. During the crisis, Chinese factory shutdowns led to immediate shortages and price surges for essential APIs, including those used in Fluticasone production. This situation prompted the Indian government to initiate the Production Linked Incentive (PLI) scheme in February 2021, aiming to bolster domestic API and KSM manufacturing. Despite these efforts, as of November 2024, India's import dependence on key pharmaceutical ingredients from China remained significant, with imports accounting for 43.45% of India's pharmaceutical imports, amounting to $3.6 billion.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 reveals a high supplier concentration in Fluticasone exports from India. The top five exporters account for 95.9% of the total export value, with CIPLA LIMITED alone contributing $184.7 million, representing a 91.0% share. This heavy reliance on a single supplier poses significant risks, including potential supply disruptions due to operational issues, regulatory actions, or strategic shifts within the company.

Access Complete Fluticasone Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 9,009 transactions across 123 markets.

Request Demo View Pricing

Frequently Asked Questions — Fluticasone Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top fluticasone exporters from India?

The leading fluticasone exporters from India are CIPLA LIMITED, HETERO LABS LIMITED, MEDISPRAY LABORATORIES PRIVATE LIMITED, and 12 others. CIPLA LIMITED leads with 91.0% market share ($184.7M). The top 5 suppliers together control 95.9% of total export value.

What is the total export value of fluticasone from India?

The total export value of fluticasone from India is $203.0M, recorded across 9,009 shipments from 239 active exporters to 123 countries. The average shipment value is $22.5K.

Which countries import fluticasone from India?

India exports fluticasone to 123 countries. The top importing countries are NETHERLANDS (34.2%), AUSTRALIA (10.1%), CANADA (5.9%), SOUTH AFRICA (5.4%), TURKEY (4.2%), which together account for 59.7% of total export value.

What is the HS code for fluticasone exports from India?

The primary HS code for fluticasone exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Fluticasone

Fluticasone

Top Fluticasone Exporters from India

Top Countries Importing Fluticasone from India

Who Supplies Fluticasone to India?

Quick Facts

Related Respiratory

Related Analysis

Need Details?

Fluticasone — Export Intelligence Video

Regulatory Landscape — Fluticasone

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Fluticasone

Supply Chain Risk Assessment — Fluticasone

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Fluticasone Trade Intelligence

Frequently Asked Questions — Fluticasone Exports from India

Who are the top fluticasone exporters from India?

What is the total export value of fluticasone from India?

Which countries import fluticasone from India?

What is the HS code for fluticasone exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of fluticasone exports from India?

Which ports handle fluticasone exports from India?

Why is India a leading exporter of fluticasone?

What certifications do Indian fluticasone exporters need?

How many buyers import fluticasone from India?

What is the market share of the top fluticasone exporter from India?

Analysis Methodology